Sapiens International (SPNS) has had the highest return since 2025 by a US stock with a market cap of $2,012+, returning 53,426.8%.
| ASSET | % RETURN |
|---|---|
Sapiens International (SPNS) | 53,426.82% |
Regencell Bioscience (RGC) | 15,274.25% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Abivax SA American Depositary Shares (ABVX) | 1,747.65% |
FiEE (FIEE) | 1,487.16% |
NovaBay Pharmaceuticals (NBY) | 1,405.13% |
Oncology Institute (TOI) | 1,099.35% |
Hycroft Mining (HYMC) | 979.65% |
Zepp Health (ZEPP) | 978.08% |
Diginex Limited Ordinary Shares (DGNX) | 773.24% |
Palvella Therapeutics (PVLA) | 763.74% |
Relmada Therapeutics (RLMD) | 742.33% |
Cidara Therapeutics (CDTX) | 715.31% |
Abits (ABTS) | 707.21% |
DeFi Development (DFDV) | 693.58% |
Sandisk (SNDK) | 685.05% |
Celcuity LLC (CELC) | 660.59% |
AXT (AXTI) | 654.95% |
Aimei Health Technology Co, Ltd Ordinary Share (AFJK) | 612.3% |
Nanobiotix (NBTX) | 611.58% |
Terns Pharmaceuticals (TERN) | 611.17% |
Haoxi Health Technology Limited Class A Ordinary Shares (HAO) | 574.45% |
Newegg Commerce (NEGG) | 553.63% |
Avino Silver & Gold Mines (ASM) | 550.55% |
Rich Sparkle Holdings Limited Ordinary Shares (ANPA) | 530.83% |
